<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2604-1227</journal-id>
<journal-title><![CDATA[Revista mexicana de oftalmología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. mex. oftalmol]]></abbrev-journal-title>
<issn>2604-1227</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Mexicana de Oftalmología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2604-12272019000300142</article-id>
<article-id pub-id-type="doi">10.24875/rmo.m19000069</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Hemangioma capilar periocular en 2018: curso natural, indicaciones para el tratamiento y opciones terapéuticas]]></article-title>
<article-title xml:lang="en"><![CDATA[Periocular capillary hemangioma in 2018: natural course, indications for treatment and therapeutic options]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Fleitman-Broder]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Médico ABC  ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<volume>93</volume>
<numero>3</numero>
<fpage>142</fpage>
<lpage>148</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S2604-12272019000300142&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S2604-12272019000300142&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S2604-12272019000300142&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen Los hemangiomas capilares son el tumor de párpado y órbita más común en la infancia. La mayoría de estos tumores no requieren tratamiento, gracias a que involucionan espontáneamente sin dejar secuelas permanentes; sin embargo, en muchos casos, el tratamiento es necesario, por ejemplo, en el caso de lesiones ambliogénicas o que pongan en riesgo la salud ocular. El tratamiento de este tipo de lesiones ha evolucionado a lo largo de los años, desde la escisión quirúrgica, pasando por el láser y los tratamientos con esteroides, todos ellos con diferentes grados de éxito y efectos secundarios. En los últimos años, gracias a un hallazgo casual de Leaute-Labreze, et al., el tratamiento de estas lesiones ha sufrido una revolución. Ahora, en el arsenal terapéutico para este tipo de lesiones contamos con fármacos betabloqueadores, que han demostrado ser altamente efectivos y con un rango de seguridad mucho mayor que los tratamientos previamente utilizados. Hoy en día existen también reportes de casos que demuestran éxito en el tratamiento de estas lesiones con aplicación tópica de esta familia de medicamentos, lo que disminuye los efectos secundarios. Al contar con modalidades terapéuticas más seguras y eficaces, es posible tratar hemangiomas que en el pasado solamente se hubieran observado, así, se disminuyen las secuelas cosméticas y el estigma social que estos niños viven al tener una lesión de esta naturaleza en el área facial.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract Capillary hemangiomas are one of the most common benign orbital and eyelid childhood tumors. Many of these tumors do not require treatment because they regress spontaneously without leaving sequelae; however, treatment is necessary in many cases, such as amblyogenic or eye-threatening lesions. Treatment of this kind of lesions has evolved from surgical excision to laser and steroids, all of them successful in different ways and with a range of side effects. In the last few years treatment has been revolutionized due to a casual finding made by Leaute-Labreze et al. Nowadays we use beta-blockers that have proved to be highly effective and with a much safer profile than previously used drugs. Several case reports have shown success by treating these lesions with topical beta-blockers. With this safer and more effective treatment, we can currently treat this lesions that in the past were just kept under observation, diminishing the cosmetic sequelae and the social stigma of patients having such lesions in their facial area.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[(Tratamiento de) Neoplasias palpebrales]]></kwd>
<kwd lng="es"><![CDATA[(Tratamiento de) Hemangioma capilar]]></kwd>
<kwd lng="es"><![CDATA[(Tratamiento de) Neoplasias orbitales]]></kwd>
<kwd lng="es"><![CDATA[(Uso terapéutico) Propanolol]]></kwd>
<kwd lng="es"><![CDATA[(Tratamiento de) Neoplasias faciales]]></kwd>
<kwd lng="en"><![CDATA[Eyelid neoplasms (therapy)]]></kwd>
<kwd lng="en"><![CDATA[Hemangioma capillary (therapy)]]></kwd>
<kwd lng="en"><![CDATA[Orbital neoplasms (therapy)]]></kwd>
<kwd lng="en"><![CDATA[Propranolol (therapeutic use)]]></kwd>
<kwd lng="en"><![CDATA[Facial neoplasms (therapy)]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoyt]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Taylor]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Pediatric Ophthalmology and Strabismus]]></source>
<year>2005</year>
<edition>3rd ed</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Elsevier Saunders]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nelson]]></surname>
<given-names><![CDATA[LB]]></given-names>
</name>
<name>
<surname><![CDATA[Olitsky]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<source><![CDATA[Harley's Pediatric Ophthalmology]]></source>
<year>2005</year>
<edition>5th ed</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincott Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Shields]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<source><![CDATA[Eyelid, Conjunctival, and Orbital Tumors]]></source>
<year>2008</year>
<edition>2nd ed</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[Lippincot Williams &amp; Wilkins]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fabian]]></surname>
<given-names><![CDATA[ID]]></given-names>
</name>
<name>
<surname><![CDATA[Ben-Zion]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Samuel]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Spierer]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma]]></article-title>
<source><![CDATA[Am J Ophthalmol]]></source>
<year>2011</year>
<volume>151</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>53-8</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Langer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[New Developments in the Management of Periocular Capillary Hemangioma in Children]]></article-title>
<source><![CDATA[J Pediatr Ophthalmol Strabismus]]></source>
<year>2011</year>
<volume>48</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>269-76</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Frank]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
<name>
<surname><![CDATA[Cowan]]></surname>
<given-names><![CDATA[BJ]]></given-names>
</name>
<name>
<surname><![CDATA[Harrop]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Astle]]></surname>
<given-names><![CDATA[WF]]></given-names>
</name>
<name>
<surname><![CDATA[McPhalen]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Visual development in infants:visual complications of periocular hemangiomas]]></article-title>
<source><![CDATA[J Plast Reconstr Aesthet Surg]]></source>
<year>2010</year>
<volume>63</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[North]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Waner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Mizeracki]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mihm]]></surname>
<given-names><![CDATA[JMC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GLUT1:a newly discovered immunohistochemical marker for juvenile hemangiomas]]></article-title>
<source><![CDATA[Hum Pathol]]></source>
<year>2000</year>
<volume>31</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>11-22</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barnes]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Kaipainen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Sanoudou]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[EJ]]></given-names>
</name>
<name>
<surname><![CDATA[Eichler]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Evidence by molecular profiling for a placental origin of infantile hemangioma]]></article-title>
<source><![CDATA[Proc Nat Acad Sci USA]]></source>
<year>2005</year>
<volume>102</volume>
<numero>52</numero>
<issue>52</issue>
<page-range>19097-102</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zimmermann]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Wiegand]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Werner]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Eivazi]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propranolol therapy for infantile haemangiomas:Review of the literature]]></article-title>
<source><![CDATA[Int J Pediatr Otorhinolaryngol]]></source>
<year>2010</year>
<volume>74</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>338-42</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Léauté-Labrèze]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Dumas de la]]></surname>
<given-names><![CDATA[Roque E]]></given-names>
</name>
<name>
<surname><![CDATA[Hubiche]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Boralevi]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Thambo]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
<name>
<surname><![CDATA[Taïeb]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Propranolol for severe haemangiomas of infancy]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2008</year>
<volume>358</volume>
<numero>24</numero>
<issue>24</issue>
<page-range>2649-51</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gawley]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Bingham]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[McGinnity]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Visual outcomes of treated periocular capillary haemangiomas in childhood:a10-year review]]></article-title>
<source><![CDATA[Acta Ophthalmol]]></source>
<year>2011</year>
<volume>89</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>396-401</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Boon]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[MacDonald]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Mulliken]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Complications of systemic corticosteroid therapy for problematic hemangioma]]></article-title>
<source><![CDATA[Plast Reconstr Surg]]></source>
<year>1999</year>
<volume>104</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1616-23</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arneja]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Mulliken]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Resection of amblyogenic periocular hemangiomas:indications and outcomes]]></article-title>
<source><![CDATA[Plast Reconstr Surg]]></source>
<year>2010</year>
<volume>125</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>274-81</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Greinwald Jr]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Burke]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Bonthius]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bauman]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[An update on the treatment of hemangiomas in children with interferon alfa-2a]]></article-title>
<source><![CDATA[Arch Otolaryngol Head Neck Surg]]></source>
<year>1999</year>
<volume>125</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>21-7</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[TS]]></given-names>
</name>
<name>
<surname><![CDATA[Eichenfield]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Friedlander]]></surname>
<given-names><![CDATA[SF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Infantile hemangiomas:an update on pathogenesis and therapy]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2013</year>
<volume>131</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>99-108</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Langer]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wagner]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical Timolol for Periocular Hemangioma:Report of Further Study]]></article-title>
<source><![CDATA[Arch Ophthalmol]]></source>
<year>2011</year>
<volume>129</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>373-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Haider]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Plager]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Neely]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Eikenberry]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Haggstrom]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Outpatient treatment of periocular infantile hemangiomas with oral propranolol]]></article-title>
<source><![CDATA[JAAPOS]]></source>
<year>2010</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>251-6</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ni]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical Treatment for Capillary Hemangioma of the Eyelid Using b-Blocker Solution]]></article-title>
<source><![CDATA[Arch Ophthalmol]]></source>
<year>2010</year>
<volume>128</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>255-6</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Semkova]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Kazandjieva]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical timolol maleate for treatment of infantile haemangiomas:preliminary results of a prospective study]]></article-title>
<source><![CDATA[Clin Exp Dermatol]]></source>
<year>2013</year>
<volume>38</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>143-6</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jha]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Mallik]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Raihan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical ophthalmic solution in infantile hemangioma]]></article-title>
<source><![CDATA[J Postgrad Med]]></source>
<year>2012</year>
<volume>58</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>163-5</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moehrle]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Léauté-Labrèze]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Röcken]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Poets]]></surname>
<given-names><![CDATA[CF]]></given-names>
</name>
<name>
<surname><![CDATA[Goelz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical Timolol for Small Hemangiomas of Infancy]]></article-title>
<source><![CDATA[Pediatr Dermatol]]></source>
<year>2013</year>
<volume>30</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>245-9</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Garcia-Millán]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Villegas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fueyo-Casado]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Burón]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Topical timolol for infantile hemangioma of the eyelid]]></article-title>
<source><![CDATA[Int J Dermatol]]></source>
<year>2013</year>
<volume>52</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>603-4</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chambers]]></surname>
<given-names><![CDATA[CB]]></given-names>
</name>
<name>
<surname><![CDATA[Katowitz]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
<name>
<surname><![CDATA[Katowitz]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Binenbaum]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary Hemangiomas]]></article-title>
<source><![CDATA[Ophthal Plast Reconstr Surg]]></source>
<year>2012</year>
<volume>28</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>103-6</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oranje]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Janmohamed]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Madern]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[de Laat]]></surname>
<given-names><![CDATA[PC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Treatment of Small Superficial Haemangioma with Timolol 0.5% Ophthalmic Solution:A Series of 20 Cases]]></article-title>
<source><![CDATA[Dermatology]]></source>
<year>2011</year>
<volume>223</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>330-4</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
